Medical resident's confidence in treatment decisions and impact on patient satisfaction in response to consumer demands in the clinical encounter

被引:0
|
作者
Houghton, B [1 ]
Galt, K [1 ]
Rich, E [1 ]
Turner, P [1 ]
Monaghan, M [1 ]
机构
[1] Creighton Univ, Omaha, NE USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
206
引用
收藏
页码:269A / 269A
页数:1
相关论文
共 50 条
  • [31] The impact of illness and treatment on the meaning of quality of life: Response shifts in patient's personal goals and concerns
    Rapkin, BD
    [J]. QUALITY OF LIFE RESEARCH, 1997, 6 (7-8) : 306 - 306
  • [32] New considerations in the medical management of early Parkinson's disease: Impact of recent clinical trials on treatment strategy
    Hauser, Robert A.
    [J]. PARKINSONISM & RELATED DISORDERS, 2009, 15 : S17 - S21
  • [33] The Impact of Epstein-Barr Virus Infection on Juvenile Idiopathic Arthritis Activity and Patient's Response to Treatment
    Opoka-Winiarska, Violetta
    Grywalska, Ewelina
    Sobiesiak, Aleksandra
    Rolinski, Jacek
    [J]. JOURNAL OF CLINICAL MEDICINE, 2020, 9 (11) : 1 - 11
  • [34] Clinical Commentary in Response To: Relationship between Patient Satisfaction and Functional Outcome Metrics 3 Months after Surgical Treatment for Distal Radius Fractures
    MacDermid, Joy C.
    [J]. JOURNAL OF HAND THERAPY, 2009, 22 (04) : 309 - 311
  • [35] Impact of 16S rDNA sequencing on clinical treatment decisions: a single center retrospective study (vol 21, 190, 2021)
    Ursenbach, Axel
    Schramm, Frederic
    Severac, Francois
    Hansmann, Yves
    Lefebvre, Nicolas
    Ruch, Yvon
    Argemi, Xavier
    [J]. BMC INFECTIOUS DISEASES, 2021, 21 (01)
  • [36] In response to the study “a randomized trial of medical cannabis in patients with stage for cancers to assess feasibility, dose requirements, impact on pain and opioid use, safety, and overall patient’s satisfaction” by Dr. Zylla and colleagues
    Mellar P. Davis
    [J]. Supportive Care in Cancer, 2022, 30 : 4579 - 4580
  • [37] In response to the study "a randomized trial of medical cannabis in patients with stage for cancers to assess feasibility, dose requirements, impact on pain and opioid use, safety, and overall patient's satisfaction" by Dr. Zylla and colleagues
    Davis, Mellar P.
    [J]. SUPPORTIVE CARE IN CANCER, 2022, 30 (06) : 4579 - 4580
  • [38] Sociodemographic and Clinical Characteristics Associated with Patient's Decision to Refuse Multiple Myeloma (MM) Treatment, and Its Impact on Outcomes
    Kumar, Vivek
    Abdulazeez, Mays F.
    Bodepudi, Srilekha
    Biswas, Suman
    Roy, Vivek
    Sher, Taimur
    Ailawadhi, Meghna
    Alegria, Victoria R.
    Paulus, Aneel
    Chanan-Khan, Asher A.
    Ailawadhi, Sikander
    [J]. BLOOD, 2019, 134
  • [39] 18FDG-PET in the evaluation of patologic response after treatment and clinical outcome in oesophageal cancer's patient
    Gasparini, M. D.
    Benti, R.
    Colombo, F. R.
    Rognoni, G. Cabrini M.
    Canzi, C.
    Gerundini, P.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S161 - S162
  • [40] Discordant CD34+cell results in peripheral blood and hematopoietic progenitor cell- apheresis product: implications for clinical decisions and impact on patient treatment
    Liwski, Courtney J.
    Padley, Douglas J.
    Gustafson, Michael P.
    Winters, Jeffrey L.
    Gastineau, Dennis A.
    Jacob, Eapen K.
    [J]. TRANSFUSION, 2014, 54 (03) : 541 - 544